AnovaOS Network Powered Patient Registry
The objective of this study is the development, implementation and management of a registry of patient data that captures clinically meaningful, real-world, data on the diagnosis, nature, course of infection, treatment(s) and outcomes in patients with complex disease globally.
| Condition(s) | Infectious Disease, Neoplasms, Diseases of the Blood and Blood-Forming Organs and Certain Disorders Involving the Immune Mechanism (D50-D89), Endocrine, Nutritional and Metabolic Diseases (E00-E89), M |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | The objective of this study is the development, implementation and management of a registry of patient data that captures clinically meaningful, real-world, data on the diagnosis, nature, course of infection, treatment(s) and outcomes in patients with complex disease globally. |
| Who can participate | Inclusion Criteria: * 18 years old or older; * Confirmed positive diagnosis of disease, condition or disorder. This will be self-reported or reported by the patient's provider, advocacy group or other patient representative; * Laboratory or other independent means of confirmation is not required but may be confirmed in clinical trials; * Able to understand and willing to sign the informed consent document; or whose legal representative has given consent to participate in the research per state and Federal requirements; * Willing and able to complete the registry questions or have the instrument(s) completed by an informed proxy; * Anticipated additional follow up with the registry once per year. Exclusion Criteria: * Subjects who do not meet the inclusion criteria for the study; * Subjects |
| Ages | 18 Years |
| Sex | All |
| Accepts healthy volunteers | Yes |
| Lead sponsor | Anova Enterprises, Inc |
| Locations | Arlington Heights, Illinois, United States |
| Start date | 2021-09-01 |
| NCT ID | NCT05013944 |
| Official listing | https://clinicaltrials.gov/study/NCT05013944 |